Home › Sudden Cardiac Arrest › NCT04972526
Resuscitative TEE Collaborative Registry
Evaluation of the Clinical Impact and Safety of Focused Transesophageal Echocardiography During Resuscitation of Critically Ill Patients in the Emergency Department and Intensive Care Settings
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting. Exclusion Criteria: * Children (age under 18 years) * Vulnerable populations
About the study
The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.
The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.
The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.
Sponsor: University of Pennsylvania · Participants: 1,000 · Started: Dec 1, 2020
Contact the study team
- James R Quinlan · Phone: 7175792198
- Felipe Teran, MD, MSCE · Phone: 9172573841
Official record on ClinicalTrials.gov — NCT04972526
Locations in the U.S.
| Illinois | Rush University Medical Center, Chicago |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.